Celcuity (CELC) News Today $12.62 -0.16 (-1.25%) (As of 10:25 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Celcuity (NASDAQ:CELC) Earns Buy Rating from Needham & Company LLCNovember 18 at 2:49 AM | americanbankingnews.comCelcuity’s Strategic Advancements and Financial Stability Support Buy RatingNovember 15, 2024 | markets.businessinsider.comCelcuity’s Strong Financial Position and Promising Drug Pipeline Support Buy Rating Despite Trial DelaysNovember 15, 2024 | markets.businessinsider.comCelcuity (NASDAQ:CELC) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $27.00 price objective on shares of Celcuity in a report on Friday.November 15, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comNeedham & Company LLC Reiterates Buy Rating for Celcuity (NASDAQ:CELC)Needham & Company LLC reiterated a "buy" rating and set a $23.00 price objective on shares of Celcuity in a research note on Friday.November 15, 2024 | marketbeat.comCelcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial ChallengesNovember 15, 2024 | finance.yahoo.comCelcuity Inc. Reports Q3 Progress and FinancialsNovember 15, 2024 | markets.businessinsider.comPromising Outlook for Celcuity’s Gedatolisib Highlighted by Positive Phase III Trial ProgressNovember 14, 2024 | markets.businessinsider.comCelcuity Inc. (CELC) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comCelcuity Inc. Reports Third Quarter Financial Results and Provides Corporate UpdateNovember 14, 2024 | globenewswire.comCelcuity (CELC) Gets a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comCelcuity Inc. To Present at Upcoming Stifel and Jefferies Investor ConferencesNovember 12, 2024 | globenewswire.comCelcuity (CELC) Scheduled to Post Earnings on ThursdayCelcuity (NASDAQ:CELC) will be releasing earnings after the market closes on Thursday, November 14, Zacks reports.November 8, 2024 | marketbeat.comCelcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference CallNovember 7, 2024 | globenewswire.comCelcuity: Breast Cancer Drug Developer With Upcoming CatalystsNovember 6, 2024 | seekingalpha.comCelcuity Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Buy" from AnalystsCelcuity Inc. (NASDAQ:CELC - Get Free Report) has earned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendatioOctober 31, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Short Interest Up 9.3% in OctoberCelcuity Inc. (NASDAQ:CELC - Get Free Report) saw a large growth in short interest in October. As of October 15th, there was short interest totalling 3,530,000 shares, a growth of 9.3% from the September 30th total of 3,230,000 shares. Based on an average daily volume of 306,800 shares, the days-to-cover ratio is currently 11.5 days.October 30, 2024 | marketbeat.comShort Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 26.7%Celcuity Inc. (NASDAQ:CELC - Get Free Report) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 3,230,000 shares, a growth of 26.7% from the September 15th total of 2,550,000 shares. Based on an average trading volume of 357,800 shares, the days-to-cover ratio is presently 9.0 days.October 14, 2024 | marketbeat.comCelcuity Inc (CELC) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid Rising ExpensesOctober 9, 2024 | finance.yahoo.comLeerink Partners Sticks to Their Buy Rating for Boundless Bio Inc. (BOLD)October 8, 2024 | markets.businessinsider.comMorgan Stanley's Strategic Reduction in Celcuity Inc HoldingsOctober 7, 2024 | gurufocus.comCelcuity (NASDAQ:CELC) PT Raised to $42.00 at Stifel NicolausStifel Nicolaus boosted their target price on shares of Celcuity from $39.00 to $42.00 and gave the stock a "buy" rating in a report on Monday.October 7, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Receives Consensus Rating of "Buy" from BrokeragesShares of Celcuity Inc. (NASDAQ:CELC - Get Free Report) have earned a consensus rating of "Buy" from the seven analysts that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on thOctober 6, 2024 | marketbeat.comPoint72 Asset Management L.P. Acquires New Shares in Celcuity Inc. (NASDAQ:CELC)Point72 Asset Management L.P. bought a new position in Celcuity Inc. (NASDAQ:CELC - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 58,077 shares of the company's stock, valued at approximatOctober 4, 2024 | marketbeat.comDriehaus Capital Management LLC Has $3.35 Million Stake in Celcuity Inc. (NASDAQ:CELC)Driehaus Capital Management LLC grew its stake in Celcuity Inc. (NASDAQ:CELC - Free Report) by 62.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 204,592 shares of the company's stock aftSeptember 30, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Short Interest Up 11.4% in SeptemberCelcuity Inc. (NASDAQ:CELC - Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,550,000 shares, a growth of 11.4% from the August 31st total of 2,290,000 shares. Based on an average daily trading volume, of 416,400 shares, the days-to-cover ratio is presently 6.1 days.September 29, 2024 | marketbeat.comBlue Owl Capital Holdings LP Acquires Shares of 65,000 Celcuity Inc. (NASDAQ:CELC)Blue Owl Capital Holdings LP acquired a new stake in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 65,000 shares of the company's stock, valued at approximately $1,065September 28, 2024 | marketbeat.comDelveInsight Business Research, LLP: CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsightSeptember 25, 2024 | finanznachrichten.deBuy Rating Affirmed: Promising Clinical Developments and Strategic FDA Engagement by IDEAYA BiosciencesSeptember 25, 2024 | markets.businessinsider.comSamlyn Capital LLC Purchases 637,190 Shares of Celcuity Inc. (NASDAQ:CELC)Samlyn Capital LLC lifted its position in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) by 92.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,326,953 shares of the company's stock afteSeptember 24, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Sees Large Volume IncreaseCelcuity (NASDAQ:CELC) Sees Unusually-High Trading VolumeSeptember 13, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Down 3.5% Celcuity (NASDAQ:CELC) Trading Down 3.5%September 12, 2024 | marketbeat.comCelcuity (CELC) Holds a Potential Game-changer in Cancer TreatmentSeptember 11, 2024 | msn.comShort Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 10.2%Celcuity Inc. (NASDAQ:CELC - Get Free Report) was the target of a large growth in short interest in August. As of August 15th, there was short interest totalling 2,490,000 shares, a growth of 10.2% from the July 31st total of 2,260,000 shares. Based on an average daily trading volume, of 386,900 shares, the short-interest ratio is presently 6.4 days.September 1, 2024 | marketbeat.comLifeSci Capital Initiates Coverage of Celcuity (CELC) with Outperform RecommendationAugust 28, 2024 | msn.comGedatolisib’s Market Potential: A Buy Rating with Optimistic Trial Outcome ProjectionsAugust 22, 2024 | markets.businessinsider.comPI3K Inhibitors Market to Observe Stunning Growth During the Study Period (2020-2034) | DelveInsightAugust 21, 2024 | finance.yahoo.comHennion & Walsh Asset Management Inc. Acquires Shares of 54,217 Celcuity Inc. (NASDAQ:CELC)Hennion & Walsh Asset Management Inc. bought a new position in Celcuity Inc. (NASDAQ:CELC - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 54,217 shares of the company's stock, valued at approAugust 21, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Q2 2024 Earnings Call TranscriptAugust 19, 2024 | insidermonkey.comCELC Mar 2025 35.000 call (CELC250321C00035000)August 17, 2024 | finance.yahoo.comCelcuity (NASDAQ:CELC) Posts Quarterly Earnings ResultsCelcuity (NASDAQ:CELC - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.71) by $0.09. During the same quarter in the prior year, the business posted ($0.66) earnings per share.August 17, 2024 | marketbeat.comBuy Rating Affirmed: Optimism for Celcuity’s Pipeline and Financial Stability Amid Clinical Trial ProgressAugust 17, 2024 | markets.businessinsider.comCelcuity Inc. (NASDAQ:CELC) Receives Consensus Rating of "Buy" from AnalystsCelcuity Inc. (NASDAQ:CELC - Get Free Report) has received a consensus recommendation of "Buy" from the six research firms that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendatAugust 17, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Gap Up to $16.33Celcuity (NASDAQ:CELC) Shares Gap Up to $16.33August 15, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ) and Celcuity (CELC)August 15, 2024 | markets.businessinsider.comCelcuity's (CELC) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $23.00 price target on shares of Celcuity in a report on Thursday.August 15, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Price Target Cut to $39.00 by Analysts at Stifel NicolausStifel Nicolaus dropped their price target on shares of Celcuity from $40.00 to $39.00 and set a "buy" rating on the stock in a research note on Thursday.August 15, 2024 | marketbeat.comOptimistic Outlook for Celcuity’s Gedatolisib in Phase III Trials Supports Buy RatingAugust 15, 2024 | markets.businessinsider.comCelcuity (NASDAQ:CELC) Stock Price Down 4.5%Celcuity (NASDAQ:CELC) Shares Down 4.5%August 14, 2024 | marketbeat.com Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. CELC Media Mentions By Week CELC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELC News Sentiment▼0.540.46▲Average Medical News Sentiment CELC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELC Articles This Week▼132▲CELC Articles Average Week Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Renalytix News Today Fortrea News Today Teladoc Health News Today Viridian Therapeutics News Today AdaptHealth News Today CareDx News Today Aveanna Healthcare News Today The Pennant Group News Today Castle Biosciences News Today agilon health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELC Stock Alerts